Strategic synapses

Scientific discovery has never been more productive. Each year, millions of publications expand the frontier of knowledge across neuroscience, biotechnology, artificial intelligence, and advanced materials. Global R&D investment now exceeds trillions of dollars annually, reflecting a sustained commitment to innovation at scale . And yet, only a small fraction of these discoveries ever become companies. This gap is not marginal. It is structural. The paradox of modern science:

From Lab to Market: The Challenge of Scientific Valorization Each year, thousands of discoveries emerge from public and private research laboratories. Yet only a fraction successfully crosses the threshold of valorization—that is, the transformation into tangible innovation: a product, a technology, a service, or a solution with real-world impact. This transition, often referred to as the “valley of death” in innovation, represents a gap between the scientific potential of an

France: An Attractive Yet Complex Innovation Ecosystem to Navigate Establishing a presence in France represents a significant opportunity for international companies in the scientific, technological, and deeptech sectors. With a rapidly evolving innovation ecosystem, a dense territorial network, and strong national support for research, France attracts a growing number of foreign players each year. However, this attractiveness comes with a challenge: understanding the adminis

Raising capital in neuroscience is not about presenting a promising scientific breakthrough. It is about demonstrating that uncertainty has been systematically identified, structured, and reduced to a level compatible with investment. In deeptech, and particularly in neuroscience, investors do not fund ideas. They fund trajectories of risk mitigation. The decisive variable is not the originality of the science alone. It is the project’s capacity to manage uncertainty across m